Teclistamab Improves Survival and Deepens Remissions in Relapsed Multiple Myeloma: Landmark Results from International Trial
In a groundbreaking development that could redefine the treatment landscape for multiple myeloma, teclistamab, a novel bispecific antibody, has demonstrated ...
